Australian & New Zealand Childrens Haematology/Oncology Group
Study Title
Phase I/Ib trial of combined 5’azacitidine and carboplatin for recurrent/refractory pediatric brain and solid tumours
Protocol ID
OZM-077 (COZMOS)
Disease (Sub Disease)
Brain and Spinal Tumours (Ependymoma)
Diagnosis Stage
Relapse/ refractory
Sponsor
Australian and New Zealand Children's Haematology Oncology Group
The Hospital for Sick Children
The Hospital for Sick Children
Links
Trial Status
Closed to Recruitment
Study Type
Treatment
Phase
Phase 1
Age Eligibility
1 year to 18 years
International registry ID's
NCT03206021
| Study Title | Phase I/Ib trial of combined 5’azacitidine and carboplatin for recurrent/refractory pediatric brain and solid tumours |
|---|---|
| Protocol ID | OZM-077 (COZMOS) |
| Disease (Sub Disease) | Brain and Spinal Tumours (Ependymoma) |
| Diagnosis Stage | Relapse/ refractory |
| Sponsor | Australian and New Zealand Children's Haematology Oncology Group/ The Hospital for Sick Children |
| Links | https://clinicaltrials.gov/ct2/show/NCT03206021 |
| Trial Status | Closed to Recruitment |
| Trial Open Date | 01/09/2019 |
| Study Type | Treatment |
| Phase | Phase 1 |
| Age Eligibility | 1 year to 18 years |
| International registry ID's | NCT03206021 |